Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21 2022 - 4:05PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today it will
participate in the 41st annual J.P. Morgan Healthcare Conference in
San Francisco. Frank Laukien, Chairman, President & CEO, Mark
Munch, Executive Vice President & President of Bruker Nano
Group, and Gerald Herman, Executive Vice President & CFO will
present on behalf of the Company on Monday, January 9th, 2023 at
10:30 AM Eastern Standard Time.
A live audio webcast of the presentation will be available on
the Investor Relations section of the Company's website at
https://ir.bruker.com. A replay of the presentation will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the event and will be
available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular, and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity, and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221221005583/en/
Investors: Justin Ward
Senior Director, Investor Relations & Corporate Development +1
(978) 663-3660 x1479 Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024